-
-
-
-
-
-
-
Elutia reports Q1 2026 results, advances FDA review for NXT-41 product
-
-
-
-
-
-
-
Elutia reports Q4 revenue up 16%, eliminates $26.9M debt
-
-
-
-
-
-
-
Elutia Delivers Robust Growth on the Strength of EluProâ„¢ Market Adoption
-
-
-
-
-
-
-
Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025
-
-
-
-
-
-
-
Elutia Announces Second Quarter 2024 Results
-
-
-
-
-
-
-
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024
-
-
-
-
-
1,224,164 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

